Trademark Overview
On Friday, April 10, 2026, a trademark application was filed for OCEMMA with the United States Patent and Trademark Office. The USPTO has given the OCEMMA trademark a serial number of 79449814. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, May 14, 2026. This trademark is owned by CELLTRION, INC.. The OCEMMA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for human use; antibodies for medical purposes; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for the treatment of inflammatory diseases.